References
- Organization WH. A global brief on hypertension: silent killer, global public health crisis. World Health Day 2013; 2013.
- Haeusler KG, Huttner HB, Kuramatsu JB. Comment on 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2019;40(25):2092.
- Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, Chen Y, Bian Z, Chen J, Meng J, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med. 2016;176(4):524–32. doi:https://doi.org/10.1001/jamainternmed.2016.0190.
- Tsukikawa M, Stacey AW. A review of hypertensive retinopathy and chorioretinopathy. Clin Optometry. 2020;12:67–73. doi:https://doi.org/10.2147/OPTO.S183492.
- Sánchez-Vicente JL, López-Herrero F, Martínez-Borrego AC, Lechón-Caballero B, Moruno-Rodríguez A, Molina-Socola FE. Hypertensive choroidopathy, retinopathy and optic neuropathy in renal transplantation failure. Arch Soc Esp Oftalmol. 2019;94(11):551–55. doi:https://doi.org/10.1016/j.oftal.2019.07.006.
- Stryjewski TP, Papakostas TD, Vavvas D. Proliferative hypertensive retinopathy. JAMA Ophthalmol. 2016;134(3):345–46. doi:https://doi.org/10.1001/jamaophthalmol.2015.5583.
- Lolin YI, Sanderson JE, Cheng SK, Chan CF, Pang CP, Woo KS, Masarei JR. Hyperhomocysteinaemia and premature coronary artery disease in the Chinese. Heart. 1996;76(2):117–22. doi:https://doi.org/10.1136/hrt.76.2.117.
- Rong D, Liu J, Jia X, Al-Nafisee D, Jia S, Sun G, Li Y, Lu W, Li H, Zhang H, et al. Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese han population. Atherosclerosis. 2017;263:205–10. doi:https://doi.org/10.1016/j.atherosclerosis.2017.05.006.
- Looker HC, Fagot-Campagna A, Gunter EW, Pfeiffer CM, Narayan KMV, Knowler WC, Hanson RL. Homocysteine as a risk factor for nephropathy and retinopathy in type 2 diabetes. Diabetologia. 2003;46(6):766–72. doi:https://doi.org/10.1007/s00125-003-1104-x.
- Huang X, Yang Y, Duan Y, Kuang YQ, Lin D. Homocysteine in retinal artery occlusive disease: a meta-analysis of cohort studies. Sci Rep. 2017;7(1):15708. doi:https://doi.org/10.1038/s41598-017-16065-2.
- Weger M, Stanger O, Deutschmann H, Simon M, Renner W, Schmut O, Semmelrock J, Haas A. Hyperhomocyst(e)Inaemia, but Not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. Br J Ophthalmol. 2001;85(7):803–06. doi:https://doi.org/10.1136/bjo.85.7.803.
- Aksu K, Turgan N, Oksel F, Keser G, Ozmen D, Kitapçioğlu G, Gümüşdiş G, Bayindir O, Doğanavşargil E. Hyperhomocysteinaemia in Behçet’s disease. Rheumatology (Oxford). 2001;40(6):687–90. doi:https://doi.org/10.1093/rheumatology/40.6.687.
- Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet. 1998;351(9095):36–37. doi:https://doi.org/10.1016/S0140-6736(05)78090-9.
- Mendis S, Athauda SB, Naser M, Takahashi K. Association between hyperhomocysteinaemia and hypertension in Sri Lankans. J Int Med Res. 1999;27(1):38–44. doi:https://doi.org/10.1177/030006059902700105.
- Golbahar J, Mostafavi E. Association between low red blood cell 5-methyltetrahydrofolate and hyperhomocysteinaemia with hypertension: a cross-sectional study. High Blood Press Cardiovasc Prev. 2012;19(4):229–35. doi:https://doi.org/10.1007/BF03297635.
- Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1974;268(6):336–45. doi:https://doi.org/10.1097/00000441-197412000-00004.
- Montalescot G, Ankri A, Chadefaux-Vekemans B, Blacher J, Philippe F, Drobinski G, Benzidia R, Kamoun P, Plasma TD. Homocysteine and the extent of atherosclerosis in patients with coronary artery disease. Int J Cardiol. 1997;60(3):295–300. doi:https://doi.org/10.1016/s0167-5273(97)00099-5.
- Whyte AF, Jones DL, Dreyer MD. Vitamin B12 deficiency causing hyperhomocysteinaemia and cerebral venous sinus thrombosis. Intern Med J. 2012;42(5):601–03. doi:https://doi.org/10.1111/j.1445-5994.2012.02777.x.
- Kwon HM, Lee Y-S, Bae H-J, Kang D-W. Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke. Stroke. 2014;45(3):871–73. doi:https://doi.org/10.1161/STROKEAHA.113.004099.